Krystal Biotech, Inc.
KRYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $97,800 | $96,042 | $88,183 | $91,139 |
| % Growth | 1.8% | 8.9% | -3.2% | – |
| Cost of Goods Sold | $5,663 | $7,165 | $5,028 | $4,949 |
| Gross Profit | $92,137 | $88,877 | $83,155 | $86,190 |
| % Margin | 94.2% | 92.5% | 94.3% | 94.6% |
| R&D Expenses | $13,185 | $14,410 | $14,255 | $13,523 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $37,578 | $35,160 | $32,723 | $31,288 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $50,763 | $49,570 | $46,978 | $44,811 |
| Operating Income | $41,374 | $39,307 | $36,177 | $41,379 |
| % Margin | 42.3% | 40.9% | 41% | 45.4% |
| Other Income/Exp. Net | $6,593 | $7,468 | $7,420 | $7,231 |
| Pre-Tax Income | $47,967 | $46,775 | $43,597 | $48,610 |
| Tax Expense | -$31,398 | $8,442 | $7,864 | $3,131 |
| Net Income | $79,365 | $38,333 | $35,733 | $45,479 |
| % Margin | 81.2% | 39.9% | 40.5% | 49.9% |
| EPS | 2.741 | 1.33 | 1.24 | 1.58 |
| % Growth | 106.1% | 7.3% | -21.5% | – |
| EPS Diluted | 2.66 | 1.29 | 1.2 | 1.52 |
| Weighted Avg Shares Out | 28,953 | 28,910 | 28,815 | 28,755 |
| Weighted Avg Shares Out Dil | 29,833 | 29,749 | 29,871 | 29,883 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,593 | $7,468 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,609 | $1,543 | $1,634 | $1,555 |
| EBITDA | $49,576 | $40,850 | $37,811 | $42,934 |
| % Margin | 50.7% | 42.5% | 42.9% | 47.1% |